OTCMKTS:EMIS Emisphere Technologies (EMIS) Stock Price, News & Analysis $7.81 0.00 (0.00%) As of 12/9/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Emisphere Technologies Stock (OTCMKTS:EMIS) Get Emisphere Technologies alerts:Sign Up Key Stats Today's Range$7.81▼$7.8150-Day Range$7.81▼$7.8152-Week Range$4.06▼$9.16VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Emisphere Technologies, trading under the symbol EMIS on the OTC market, is a drug‐delivery company specializing in proprietary technologies designed to enhance the oral absorption of therapeutic compounds. The company’s core innovation, the Eligen® carrier system, facilitates the transport of macromolecules—such as peptides, proteins and small molecules—across the intestinal lining, addressing a key barrier in orally administered therapies. Over the years, Emisphere has established multiple collaborations and licensing agreements with leading pharmaceutical and biotechnology firms to apply its Eligen platform across a range of therapeutic areas. These partnerships have explored oral formulations for therapies including insulin, parathyroid hormone and vitamins, as well as small‐molecule drugs with limited bioavailability. The company’s research and development efforts have been supported by an extensive patent portfolio, protecting both composition of matter and formulation processes in major markets worldwide. Headquartered in Roseland, New Jersey, Emisphere Technologies serves a global customer base through its network of strategic alliances in North America, Europe and Asia. The company’s leadership team combines expertise in pharmaceutical sciences, business development and regulatory affairs, driving efforts to advance clinical programs and expand the application of its oral delivery platforms. Emisphere’s focus remains on bridging the gap between laboratory‐scale innovation and commercial viability for oral formulations of traditionally injectable or poorly absorbed drugs.AI Generated. May Contain Errors. Read More Receive EMIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emisphere Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EMIS Stock News HeadlinesEarnings call: SWK Holdings focuses on life science finance growthMay 18, 2024 | au.investing.comExco Technologies Limited (XTC.TO)March 3, 2024 | ca.finance.yahoo.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.September 22 at 2:00 AM | Priority Gold (Ad)Insulin pill could free diabetics from jabsDecember 11, 2023 | dailymail.co.ukSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the FirmNovember 19, 2023 | barrons.comEMIS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Emisphere Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 23, 2023 | businesswire.comEntwistle & Cappucci LLP Files a Securities Class Action Complaint Against Emisphere Technologies, Inc.October 5, 2023 | benzinga.comBuccal Drug Delivery System Global Market Report 2023May 8, 2023 | finance.yahoo.comSee More Headlines EMIS Stock Analysis - Frequently Asked Questions How have EMIS shares performed this year? Emisphere Technologies' stock was trading at $7.81 on January 1st, 2025. Since then, EMIS stock has increased by 0.0% and is now trading at $7.81. How were Emisphere Technologies' earnings last quarter? Emisphere Technologies Inc. (OTCMKTS:EMIS) issued its earnings results on Friday, May, 12th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $0.22 million for the quarter. How do I buy shares of Emisphere Technologies? Shares of EMIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Emisphere Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Emisphere Technologies investors own include Novo Nordisk A/S (NVO), Fulcrum Therapeutics (FULC), VIVUS (VVUS), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA) and Capricor Therapeutics (CAPR). Company Calendar Last Earnings5/12/2017Today9/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:EMIS CIK805326 Webwww.emisphere.com Phone973-532-8000Fax973-422-0125Employees6Year Founded1986Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:EMIS) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emisphere Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emisphere Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.